Factors affecting the abundance of uranium isotopes in body tissues and excreta following the deposition of enriched uranium dioxide in the lungs. The radiological implications

G. N. Stradling, H. Smith, John Cooper, S. E. Ham, N. Cooke, D. Sedgwick, R. S. Shaw

    Research output: Contribution to journalArticlepeer-review

    2 Citations (Scopus)

    Abstract

    At British Nuclear Fuels Ltd, (BNFL). Springfields Works, the fabrication of ceramic fuel pellets for use in some types of nuclear reactors requires the manipulaton of uranium dioxide (238UO2) powders variably enriched in 235U (2-5%) and 234U (0.02-0.05%). To ensure that workers are not unacceptably exposed to uranium dust, in addition to routine air sampling and bioassay, periodic estimates of deposition in the lungs are made by external counting of the chest; 235U is detected by its 185-keV photon and 238U by the 90-keV photon emitted by the daughter nuclide 234Th.

    Original languageEnglish
    Pages (from-to)434-438
    Number of pages5
    JournalHealth Physics
    Volume46
    Issue number2
    Publication statusPublished - 1984

    Fingerprint

    Dive into the research topics of 'Factors affecting the abundance of uranium isotopes in body tissues and excreta following the deposition of enriched uranium dioxide in the lungs. The radiological implications'. Together they form a unique fingerprint.

    Cite this